News
USAMRIID researchers are testing a promising new biological threat detection method in training scenarios, demonstrating its suitability for field use.
Advances in NGS, affordable instruments like Illumina MiSeq, AI-driven bioinformatics, and strategic partnerships drive ...
13d
AZoLifeSciences on MSNBroad Spectrum Pathogen Detection Achieved Through Metagenomic SequencingA recent study on the application of Metagenomic next-generation sequencing (mNGS) found that mNGS can achieve early ...
Roche and Broad Clinical Labs collaborate to accelerate adoption of cutting-edge SBX sequencing technology: Basel Saturday, May 24, 2025, 10:00 Hrs [IST] Roche announced a strateg ...
CD Genomics, a leader in next-generation sequencing services, has launched an advanced Whole Genome Bisulfite Sequencing (WGBS) platform. This initiative aims to provide researchers with a ...
The deals cover development and commercialization of next-generation sequencing and digital PCR assays for minimal residual disease detection.
Next-generation metagenomic sequencing has uncovered key differences in bronchiectasis pathogens and resistance genes across Europe.
Featuring New Advances in Automated Bioinformatics and HIV Drug Resistance Detection Using Next-Generation Sequencing ...
The strategic collaboration with Broad Clinical Labs will explore and develop applications using Roche’s SBX sequencing technology1, with an initial focus on critically ill newborns and their parents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results